Eraaya Lifespaces Q2 FY26: Loss ₹326 Cr, Key Risks

Board approval puts September-quarter numbers in focus

Eraaya Lifespaces Ltd said its board approved the company’s financial results on April 18, 2026, bringing renewed attention to its September 30, 2025 quarter performance. The company reported a sharp gap between revenue and profitability at the consolidated level. It also flagged that strategic and legal overhangs continue to shape investor attention. Two areas stand out in disclosures: the Ebix Inc transaction and long-running Foreign Currency Convertible Bonds (FCCBs) disputes. Alongside the financial results, the company disclosed key management and compliance updates.

Consolidated performance: revenue growth, large quarterly loss

For the quarter ended September 30, 2025, Eraaya Lifespaces reported consolidated revenue of ₹635.69 crore and a consolidated net loss of ₹326.33 crore. The unaudited results also showed that losses widened over the half-year period. For the half-year ended September 30, 2025, the company reported consolidated revenue of ₹1,244.97 crore and a consolidated loss after tax of ₹480.17 crore. The disclosures present a business with high reported topline but persistent losses. The company has positioned its revenue growth as continuing even while disputes and approvals remain pending.

Standalone numbers remain small compared with consolidated scale

In the same results overview, the company reported standalone revenue of ₹5.87 crore and a standalone net loss of ₹47.53 crore. Standalone revenue was stated to have increased 372.79% year-on-year. But the consolidated picture dominated the narrative because it reflects the larger operating scale after group-level changes tied to Ebix. The company also indicated that consolidated revenue surged to ₹660.40 crore in the results overview, highlighting a separate consolidated revenue figure alongside the ₹635.69 crore quarterly revenue stated in the unaudited results. The filings, taken together, emphasise that consolidated performance is the key lens for tracking the company’s financial stress.

Key financial snapshot

Negative net worth, MAT credit write-off, and regulatory penalties

A major balance-sheet marker in the disclosures is the shift to negative consolidated equity of -₹94.84 crore as of September 30, 2025, compared with ₹30.13 crore in March 2025. The company also wrote off ₹277.09 crore of MAT credit entitlement, stating it was considered unrecoverable. Separately, the Enforcement Directorate imposed a ₹32.91 crore penalty for FEMA non-compliance, adding to the regulatory burden referenced in the results overview. The company also recognised a ₹5.78 crore loan impairment provision because borrower Vitasta Software India Pvt. Ltd. was admitted into CIRP. These items, combined with the quarterly losses, underline the stress points that investors typically monitor when net worth turns negative.

Ebix Inc transaction: diversification push, but approvals and scrutiny

Eraaya’s strategic direction has been closely tied to Ebix Inc, described as a global tech and financial solutions provider. The company’s disclosures refer to the Ebix Inc transaction as facing substantial hurdles, including pending regulatory approvals and the need for shareholder approval for material related-party transactions. At the same time, the filings also reference Eraaya’s acquisition of Ebix Inc and its global subsidiaries in August 2024 and describe consolidated scale-up linked to Ebix and its subsidiaries. The company has positioned the move as diversification, while acknowledging the transaction’s governance and approval requirements. In sector context, the company’s strategy was contrasted with peers such as Macrotech Developers, Prestige Estates Projects, and Godrej Properties, which remain focused on core real estate development.

FCCB disputes: contingent liability and litigation overhang

Eraaya Lifespaces remains entangled in legal disputes involving FCCBs, which the company indicated have created contingent liabilities and ongoing litigation exposure. A specific contingent liability disclosed is ₹104.97 crore linked to unrecognised interest on FCCBs. The company also referenced legal cases that include recovery of USD 40 million in FCCB proceeds, with bondholders questioning corporate actions. Disclosures also pointed to previous NCLT orders and ongoing litigations, with deferred liability recognition requiring careful management. In addition, the company’s filings referenced that an arbitration with Vikas Lifecare concluded on July 8, 2025, tied to a financial dispute connected to the Ebix transaction.

Ebix Payment Services matter: ₹180 crore settlement gets court approval

In another update linked to the Ebix group structure, Eraaya said a long-standing shareholder matter relating to Ebix Payment Services was resolved after the Bombay High Court approved consent terms. The company disclosed a negotiated framework for a complete buyout of minority shareholding in Ebix Payment Services Private Limited for approximately ₹180.00 crore, to be discharged over an agreed timeframe. Eraaya described the matter as a legacy issue tied to prior Ebix group arrangements and said it was not part of the Chapter 11 resolution process or the acquisition consideration paid by Eraaya. The company said the resolution removes structural constraints and improves operational flexibility within the payments business.

Compliance and leadership changes alongside ongoing uncertainty

On the governance side, Eraaya said Ms. Urvashi Upadhyay was appointed as Company Secretary, effective immediately. Separately, disclosures around the share capital reconciliation audit report for the quarter ended March 31, 2026 noted that the previous Company Secretary and Compliance Officer, Ms. Vasudha Aggarwal, resigned effective January 17, 2026. The company also reported management changes filed on March 28, 2026, including the cessation of Mr. C.S. Murty as CFO and the appointment of Mr. Sushil Gupta as CEO and Mr. Ashish Sharma as CFO. In compliance filings, the company said it reported no deviation in fund utilisation for the quarter ended December 31, 2025, and stated that no FCCB funds were raised during Q3FY26 while preferential issue proceeds were used as per stated objectives. It also disclosed share capital details including total issued capital of 20,66,94,160 shares and conversion of 73,60,000 warrants into equity shares during January 2026.

Risk checklist investors are tracking

Why the numbers matter for markets

The reported combination of high consolidated revenue and deep consolidated losses is central to how investors will read Eraaya’s near-term risk profile. Negative net worth, a large MAT credit write-off, and disclosed penalties increase scrutiny on liquidity, obligations, and governance execution. The Ebix-linked disclosures add another layer because pending approvals and shareholder consent for material related-party transactions can affect how quickly the group can stabilise its structure. Meanwhile, FCCB disputes and contingent liabilities remain an overhang because they can influence cash outflows, disclosures, and legal timelines. For investors, the most trackable catalysts in the filings are updates on regulatory and shareholder approvals tied to Ebix-related matters, and any measurable progress in FCCB litigation resolution.

Conclusion: revenue scale-up, but unresolved legal and balance-sheet strain

Eraaya Lifespaces’ September 2025 quarter results showed consolidated revenue of ₹635.69 crore alongside a consolidated loss of ₹326.33 crore, with half-year losses extending to ₹480.17 crore. Even as the company reported governance updates and resolutions on specific legacy matters, the bigger uncertainties around FCCB disputes and Ebix-related approvals remained open in disclosures. The next set of developments investors are likely to watch include regulatory updates, the status of shareholder approvals for material related-party transactions, and any change in the FCCB litigation position disclosed by the company.